These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 12423134)
21. Synthesis and biological properties of iron chelators based on a bis-2-(2-hydroxy-phenyl)-thiazole-4-carboxamide or -thiocarboxamide (BHPTC) scaffold. Rodriguez-Lucena D; Gaboriau F; Rivault F; Schalk IJ; Lescoat G; Mislin GL Bioorg Med Chem; 2010 Jan; 18(2):689-95. PubMed ID: 20036563 [TBL] [Abstract][Full Text] [Related]
22. Synthesis, characterization and in vitro anticancer evaluations of two novel derivatives of deferasirox iron chelator. Salehi S; Saljooghi ASh; Shiri A Eur J Pharmacol; 2016 Jun; 781():209-17. PubMed ID: 27090924 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives. Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and cytotoxicity of amine-borane adducts of cyclohexylamines and toluidines. Burnham BS; Chen SY; Sood A; Spielvogel BF; Hall IH Pharmazie; 1995 Dec; 50(12):779-83. PubMed ID: 8584554 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and anti-tumor activity of 2-amino-3-cyano-6-(1H-indol-3-yl)-4-phenylpyridine derivatives in vitro. Zhang F; Zhao Y; Sun L; Ding L; Gu Y; Gong P Eur J Med Chem; 2011 Jul; 46(7):3149-57. PubMed ID: 21514012 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of 2,3-diarylimidazo[1,2-a]pyridines as antileishmanial agents. Marhadour S; Marchand P; Pagniez F; Bazin MA; Picot C; Lozach O; Ruchaud S; Antoine M; Meijer L; Rachidi N; Le Pape P Eur J Med Chem; 2012 Dec; 58():543-56. PubMed ID: 23164660 [TBL] [Abstract][Full Text] [Related]
27. Study on the cytotoxic activity of platinum(II) complexes of (1R,2R)-N(1)-cyclopentyl-1,2-cyclohexanediamine with substituted malonate derivatives. Zhou Z; Chen F; Xu G; Gou S Bioorg Med Chem Lett; 2016 Jan; 26(2):322-327. PubMed ID: 26711148 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and in vitro cytotoxic activity evaluation of novel heterocycle bridged carbothioamide type isosteviol derivatives as antitumor agents. Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM Bioorg Med Chem Lett; 2013 Mar; 23(5):1343-6. PubMed ID: 23347685 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno[2,3-d]pyrimidine derivatives. Kassab AE; Gedawy EM Eur J Med Chem; 2013 May; 63():224-30. PubMed ID: 23501108 [TBL] [Abstract][Full Text] [Related]
30. Synthesis of potent taxoids for tumor-specific delivery using monoclonal antibodies. Miller ML; Roller EE; Wu X; Leece BA; Goldmacher VS; Chari RV; Ojima I Bioorg Med Chem Lett; 2004 Aug; 14(15):4079-82. PubMed ID: 15225730 [TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors. Zhu W; Wang W; Xu S; Tang Q; Luo R; Wang M; Gong P; Zheng P Bioorg Med Chem; 2016 Feb; 24(4):812-9. PubMed ID: 26810712 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines. Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and in vitro antitumor activity of novel 2-alkyl-5-methoxycarbonyl-11-methyl-6H-pyrido[4,3-b]carbazol-2-ium and 2-alkylellipticin-2-ium chloride derivatives. Mori R; Kato A; Komenoi K; Kurasaki H; Iijima T; Kawagoshi M; Kiran YB; Takeda S; Sakai N; Konakahara T Eur J Med Chem; 2014 Jul; 82():16-35. PubMed ID: 24863982 [TBL] [Abstract][Full Text] [Related]
34. Novel ferrocenic steroidal drug derivatives and their bioactivities. Manosroi J; Rueanto K; Boonpisuttinant K; Manosroi W; Biot C; Akazawa H; Akihisa T; Issarangporn W; Manosroi A J Med Chem; 2010 May; 53(10):3937-43. PubMed ID: 20408531 [TBL] [Abstract][Full Text] [Related]
35. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation. Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological activity of 2,4-di-p-phenolyl-6-2-furanyl-pyridine as a potent topoisomerase II poison. Karki R; Park C; Jun KY; Kadayat TM; Lee ES; Kwon Y Eur J Med Chem; 2015 Jan; 90():360-78. PubMed ID: 25437622 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of novel polyaminocarboxylate-based antitumor agents. Chong HS; Ma X; Lee H; Bui P; Song HA; Birch N J Med Chem; 2008 Apr; 51(7):2208-15. PubMed ID: 18345610 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and cytotoxic evaluation of substituted sulfonyl-N-hydroxyguanidine derivatives as potential antitumor agents. Chern JW; Leu YL; Wang SS; Jou R; Lee CF; Tsou PC; Hsu SC; Liaw YC; Lin HM J Med Chem; 1997 Jul; 40(14):2276-86. PubMed ID: 9216847 [TBL] [Abstract][Full Text] [Related]
39. Halogenated 2'-benzoylpyridine thiosemicarbazone (XBpT) chelators with potent and selective anti-neoplastic activity: relationship to intracellular redox activity. Stefani C; Punnia-Moorthy G; Lovejoy DB; Jansson PJ; Kalinowski DS; Sharpe PC; Bernhardt PV; Richardson DR J Med Chem; 2011 Oct; 54(19):6936-48. PubMed ID: 21846118 [TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of novel pyrenyl derivatives as anticancer agents. Bandyopadhyay D; Sanchez JL; Guerrero AM; Chang FM; Granados JC; Short JD; Banik BK Eur J Med Chem; 2015 Jan; 89():851-62. PubMed ID: 25462285 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]